Research And Development Expense

Name: Celldex Therapeutics Research And Development Expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Celldex Therapeutics·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$52.61M	$54.2M	$62.93M	$75.33M	$73M
Total	$52.61M	$54.2M	$62.93M	$75.33M	$73M

Segments

Business SegmentsView metric